News - 2020

      November 18, 2020 News

      Oblique Therapeutics AB raises 98 MSEK

      in a private placement investment round.

      Read more

      October 19, 2020 News

      This is our first Abiprot patent.

      We hope that many more will follow.

      Read more

      October 8, 2020 News

      Oblique Therapeutics AB together with collaborators

      at Sahlgrenska University Hospital (Gothenburg) and Karolinska Institutet (Stockholm) has been granted 5MSEK.

      Read more

      September 21, 2020 Event

      24th Sept 2020 – Oblique Therapeutics

      is delighted to be invited to speak at “Biopharma Conclave 2020”.

      Read more

      September 14, 2020 Event

      Oblique Therapeutics is honored to participate

      as speaker to the 2nd Edition RAS-Targeted Drug Development Congress 15th September 2020.

      Read more

      June 29, 2020 News

      Oblique Therapeutics and Targovax enter collaboration

      to target mutant RAS cancers by combining their ONCOS and Abiprot™ platforms.

      Read more

      June 11, 2020 News

      Oblique Therapeutics AB has identified

      a potentially important epitope for generation of SARS-CoV-2 antibodies.

      Read more

      June 4, 2020 News

      General Meeting 2020

      Oblique Therapeutics AB – Notice to the annual general meeting 2020.

      Read more
      1 2 3 7